228 related articles for article (PubMed ID: 2378989)
1. Acute upper gastrointestinal graft-versus-host disease: clinical significance and response to immunosuppressive therapy.
Weisdorf DJ; Snover DC; Haake R; Miller WJ; McGlave PB; Blazar B; Ramsay NK; Kersey JH; Filipovich A
Blood; 1990 Aug; 76(3):624-9. PubMed ID: 2378989
[TBL] [Abstract][Full Text] [Related]
2. Simultaneous upper and lower endoscopic biopsy in the diagnosis of intestinal graft-versus-host disease.
Roy J; Snover D; Weisdorf S; Mulvahill A; Filipovich A; Weisdorf D
Transplantation; 1991 Mar; 51(3):642-6. PubMed ID: 2006521
[TBL] [Abstract][Full Text] [Related]
3. Gastrointestinal involvement in chronic graft-versus-host disease: a clinicopathologic study.
Akpek G; Chinratanalab W; Lee LA; Torbenson M; Hallick JP; Anders V; Vogelsang GB
Biol Blood Marrow Transplant; 2003 Jan; 9(1):46-51. PubMed ID: 12533741
[TBL] [Abstract][Full Text] [Related]
4. Histologic Grade 1 Is Associated With Increased Nonrelapsed Mortality in Lower Gastrointestinal Graft Versus Host Disease.
Im JS; Abraham SC; Saliba RM; Rondon G; Ross WA; Rashid A; Shpall EJ; Popat U; Qazilbash MH; Hosing C; Oran B; Shah N; Tewari P; Nieto Y; Kebriaei P; Champlin RE; Alousi AM
Am J Surg Pathol; 2017 Nov; 41(11):1483-1490. PubMed ID: 28834808
[TBL] [Abstract][Full Text] [Related]
5. Endoscopic findings predict the histologic diagnosis in gastrointestinal graft-versus-host disease.
Cruz-Correa M; Poonawala A; Abraham SC; Wu TT; Zahurak M; Vogelsang G; Kalloo AN; Lee LA
Endoscopy; 2002 Oct; 34(10):808-13. PubMed ID: 12244503
[TBL] [Abstract][Full Text] [Related]
6. Treatment of moderate/severe acute graft-versus-host disease after allogeneic bone marrow transplantation: an analysis of clinical risk features and outcome.
Weisdorf D; Haake R; Blazar B; Miller W; McGlave P; Ramsay N; Kersey J; Filipovich A
Blood; 1990 Feb; 75(4):1024-30. PubMed ID: 2302454
[TBL] [Abstract][Full Text] [Related]
7. Gastric graft-versus-host disease: a blinded histologic study.
Washington K; Bentley RC; Green A; Olson J; Treem WR; Krigman HR
Am J Surg Pathol; 1997 Sep; 21(9):1037-46. PubMed ID: 9298880
[TBL] [Abstract][Full Text] [Related]
8. Intra-arterial catheter directed therapy for severe graft-versus-host disease.
Shapira MY; Bloom AI; Or R; Sasson T; Nagler A; Resnick IB; Aker M; Zilberman I; Slavin S; Verstanding A
Br J Haematol; 2002 Dec; 119(3):760-4. PubMed ID: 12437655
[TBL] [Abstract][Full Text] [Related]
9. Acute gastrointestinal graft-versus-host disease in pediatric patients: serum albumin on day 5 from initiation of therapy correlates with nonrelapse mortality and overall survival.
Goussetis E; Paisiou A; Kitra V; Peristeri I; Vessalas G; Stefanaki K; Panayotou I; Giamaiou K; Kontou E; Kitzoni M; Dimopoulou MN; Karkelis S; Kafritsa Y; Rapsomaniki E; Papassotiriou I; Tsirigotis P; Roma E; Graphakos S
Biol Blood Marrow Transplant; 2011 Jul; 17(7):1058-66. PubMed ID: 21073975
[TBL] [Abstract][Full Text] [Related]
10. Severity of acute gastrointestinal graft-vs-host disease is associated with incidence of bloodstream infection after adult allogeneic hematopoietic stem cell transplantation.
Modi A; Rybicki L; Majhail NS; Mossad SB
Transpl Infect Dis; 2020 Feb; 22(1):e13217. PubMed ID: 31769584
[TBL] [Abstract][Full Text] [Related]
11. Diagnosis of gastrointestinal graft-versus-host disease--is rectal biopsy enough?
Nydegger A; Catto-Smith AG; Tiedemann K; Hardikar W
Pediatr Blood Cancer; 2007 May; 48(5):561-6. PubMed ID: 16862539
[TBL] [Abstract][Full Text] [Related]
12. Prospective evaluation for upper gastrointestinal tract acute graft-versus-host disease after hematopoietic stem cell transplantation.
Wakui M; Okamoto S; Ishida A; Kobayashi H; Watanabe R; Yajima T; Iwao Y; Hisamatsu T; Hibi T; Ikeda Y
Bone Marrow Transplant; 1999 Mar; 23(6):573-8. PubMed ID: 10217188
[TBL] [Abstract][Full Text] [Related]
13. CD31 mismatching affects marrow transplantation outcome.
Grumet FC; Hiraki DD; Brown BWM ; Zehnder JL; Zacks ES; Draksharapu A; Parnes J; Negrin RS
Biol Blood Marrow Transplant; 2001; 7(9):503-12. PubMed ID: 11669217
[TBL] [Abstract][Full Text] [Related]
14. Early antithymocyte globulin therapy improves survival in patients with steroid-resistant acute graft-versus-host disease.
MacMillan ML; Weisdorf DJ; Davies SM; DeFor TE; Burns LJ; Ramsay NK; Wagner JE; Blazar BR
Biol Blood Marrow Transplant; 2002; 8(1):40-6. PubMed ID: 11858189
[TBL] [Abstract][Full Text] [Related]
15. Response of 443 patients to steroids as primary therapy for acute graft-versus-host disease: comparison of grading systems.
MacMillan ML; Weisdorf DJ; Wagner JE; DeFor TE; Burns LJ; Ramsay NK; Davies SM; Blazar BR
Biol Blood Marrow Transplant; 2002; 8(7):387-94. PubMed ID: 12171485
[TBL] [Abstract][Full Text] [Related]
16. T-cell frequency analysis does not predict the incidence of graft-versus-host disease in HLA-matched sibling bone marrow transplantation.
Wang XN; Taylor PR; Skinner R; Jackson GH; Proctor SJ; Hedley D; Dickinson AM
Transplantation; 2000 Aug; 70(3):488-93. PubMed ID: 10949192
[TBL] [Abstract][Full Text] [Related]
17. Late Gastrointestinal Complications of Allogeneic Hematopoietic Stem Cell Transplantation in Adults.
Sung AD; Hassan S; Cardona DM; Wild D; Nichols KR; Mehdikhani H; Balmadrid B; Detweiler CJ; Shealy M; Cirrincione C; Li Z; Poleski M; Dalton TE; Siamakpour-Reihani S; Chao NJ; Sullivan KM
Biol Blood Marrow Transplant; 2018 Apr; 24(4):734-740. PubMed ID: 29246821
[TBL] [Abstract][Full Text] [Related]
18. Diagnostic Utility of Endoscopy and Biopsy in Suspected Acute Gastrointestinal Graft-versus-Host Disease after Hematopoietic Progenitor Cell Transplantation.
Scott AP; Tey SK; Butler J; Kennedy GA
Biol Blood Marrow Transplant; 2018 Jun; 24(6):1294-1298. PubMed ID: 29410342
[TBL] [Abstract][Full Text] [Related]
19. T-cell depletion plus salvage immunotherapy with donor leukocyte infusions as a strategy to treat chronic-phase chronic myelogenous leukemia patients undergoing HLA-identical sibling marrow transplantation.
Drobyski WR; Hessner MJ; Klein JP; Kabler-Babbitt C; Vesole DH; Margolis DA; Keever-Taylor CA
Blood; 1999 Jul; 94(2):434-41. PubMed ID: 10397710
[TBL] [Abstract][Full Text] [Related]
20. Quantitative assessment of posttransplant host-specific interleukin-2-secreting T-helper cell precursors in patients with and without acute graft-versus-host disease after allogeneic HLA-identical sibling bone marrow transplantation.
Nierle T; Bunjes D; Arnold R; Heimpel H; Theobald M
Blood; 1993 Feb; 81(3):841-8. PubMed ID: 8427976
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
